Kenneth W. Kross

1.2k total citations
32 papers, 914 citations indexed

About

Kenneth W. Kross is a scholar working on Immunology, Oncology and Otorhinolaryngology. According to data from OpenAlex, Kenneth W. Kross has authored 32 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Oncology and 9 papers in Otorhinolaryngology. Recurrent topics in Kenneth W. Kross's work include Head and Neck Cancer Studies (8 papers), Advanced Chemical Sensor Technologies (7 papers) and Immune Response and Inflammation (7 papers). Kenneth W. Kross is often cited by papers focused on Head and Neck Cancer Studies (8 papers), Advanced Chemical Sensor Technologies (7 papers) and Immune Response and Inflammation (7 papers). Kenneth W. Kross collaborates with scholars based in Netherlands, Norway and United States. Kenneth W. Kross's co-authors include Bernd Kremer, Frank Hoebers, Anne‐Marie C. Dingemans, Hans Jørgen Aarstad, Boukje A. C. van Dijk, Erik van Werkhoven, Michiel W. M. van den Brekel, Jan Olofsson, John‐Helge Heimdal and John Helge Heimdal and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Kenneth W. Kross

32 papers receiving 899 citations

Peers

Countries citing papers authored by Kenneth W. Kross

Since Specialization

Citations

This map shows the geographic impact of Kenneth W. Kross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth W. Kross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth W. Kross more than expected).

Fields of papers citing papers by Kenneth W. Kross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth W. Kross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth W. Kross. The network helps show where Kenneth W. Kross may publish in the future.

Co-authorship network of co-authors of Kenneth W. Kross

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth W. Kross. A scholar is included among the top collaborators of Kenneth W. Kross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth W. Kross. Kenneth W. Kross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Detecting head and neck squamous carcinoma using a portable handheld electronic nose 2020 ·Head & Neck ·(unknown), (unknown), (unknown), Bernd Kremer, Kenneth W. Kross	16
2	Training and Validating a Portable Electronic Nose for Lung Cancer Screening 2018 ·Journal of Thoracic Oncology ·(unknown), (unknown), Anne‐Marie C. Dingemans, Bernd Kremer, Kenneth W. Kross	104
3	Experiences and preferences of patients visiting a head and neck oncology outpatient clinic: a qualitative study 2017 ·European Archives of Oto-Rhino-Laryngology ·Jeroen Bisschop, (unknown), (unknown), (unknown), Bernd Kremer, Kenneth W. Kross	15
4	In vitro Monocyte IL‐6 Secretion Levels Following Stimulation with Autologous Spheroids Derived from Tumour or Benign Mucosa Predict Long‐term Survival in Head and Neck Squamous Cell Carcinoma Patients 2016 ·Scandinavian Journal of Immunology ·Hans Jørgen Aarstad, (unknown), (unknown), (unknown), Olav Karsten Vintermyr, Kenneth W. Kross, (unknown), John Helge Heimdal	5
5	Feasibility of electronic nose technology for discriminating between head and neck, bladder, and colon carcinomas 2016 ·European Archives of Oto-Rhino-Laryngology ·(unknown), (unknown), (unknown), (unknown), Ad Masclee, B. Kremer, Kenneth W. Kross	52
6	Differentiating head and neck carcinoma from lung carcinoma with an electronic nose: a proof of concept study 2016 ·European Archives of Oto-Rhino-Laryngology ·(unknown), (unknown), (unknown), Anne‐Marie C. Dingemans, Bernd Kremer, Kenneth W. Kross	49
7	Intestinal‐type sinonasal adenocarcinomas: The road to molecular diagnosis and personalized treatment 2016 ·Head & Neck ·Ann Hoeben, (unknown), Frank Hoebers, Kenneth W. Kross, C.M.L. Driessen, Pieter J. Slootweg, V.C.G. Tjan-Heijnen, Carla van Herpen	30
8	Peripheral blood monocyte and T‐lymphocyte activation levels at diagnosis predict long‐term survival in head and neck squamous cell carcinoma patients 2015 ·Apmis ·Hans Jørgen Aarstad, Olav Karsten Vintermyr, Elling Ulvestad, (unknown), (unknown), Kenneth W. Kross, John Helge Heimdal	14
9	Ultrasound-guided fine-needle aspiration cytology as a diagnostic tool in comparison to ultrasound and MRI for staging in oral- and oropharyngeal squamous cell tumors 2015 ·Journal of Cranio-Maxillofacial Surgery ·(unknown), Anita Kloss‐Brandstätter, Annika A. R. Stadler, Kenneth W. Kross, Kensuke Yamauchi, Dominik Ketelsen, Peter Keßler, Bernd Lethaus	11
10	In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma 2015 ·PLoS ONE ·(unknown), (unknown), Olav Karsten Vintermyr, Elling Ulvestad, Kenneth W. Kross, John Helge Heimdal, (unknown), (unknown)	8
11	Definitive radiation therapy for treatment of laryngeal carcinoma 2013 ·Strahlentherapie und Onkologie ·Frank Hoebers, Eduardo Ríos, Esther G.C. Troost, (unknown), Kenneth W. Kross, Martin Lacko, Roy Lalisang, B. Kremer, J.D. de Jong	15
12	The Expression of Estrogen and Progesterone Receptors in the Human Larynx 2013 ·Journal of Voice ·Jan Wouter Brunings, (unknown), Carine J. Peutz‐Kootstra, Kenneth W. Kross	22
13	Laryngeal tuberculosis presenting as a supraglottic carcinoma: a case report and review of the literature 2009 ·Journal of Medical Case Reports ·Yvette E. Smulders, (unknown), Martin Lacko, (unknown), Kenneth W. Kross	28
14	Co‐culture of Head and Neck Squamous Cell Carcinoma Spheroids with Autologous Monocytes Predicts Prognosis 2008 ·Scandinavian Journal of Immunology ·Kenneth W. Kross, John Helge Heimdal, (unknown), Jan Olofsson, Hans Jørgen Aarstad	25
15	Stimulated monocyte IL-6 secretion predicts survival of patients with head and neck squamous cell carcinoma 2008 ·BMC Cancer ·John‐Helge Heimdal, Kenneth W. Kross, (unknown), Jan Olofsson, Hans Jørgen Aarstad	15
16	Tumour-associated macrophages secrete IL-6 and MCP-1 in head and neck squamous cell carcinoma tissue 2006 ·Acta Oto-Laryngologica ·Kenneth W. Kross, John‐Helge Heimdal, (unknown), Jan Olofson, Hans Jørgen Aarstad	13
17	Viable head and neck tumor spheroids stimulate in vitro autologous monocyte MCP-1 secretion through soluble substances and CD14/lectin-like receptors 2005 ·European Archives of Oto-Rhino-Laryngology ·(unknown), John‐Helge Heimdal, Kenneth W. Kross, Jan Olofsson, Hans Jørgen Aarstad	5
18	Head and neck squamous cell carcinoma spheroid- and monocyte spheroid-stimulated IL-6 and monocyte chemotactic protein-1 secretion are related to TNM stage, inflammatory state and tumor macrophage density 2005 ·Acta Oto-Laryngologica ·Kenneth W. Kross, John‐Helge Heimdal, (unknown), Jan Olofsson, Hans Jørgen Aarstad	14
19	Mechanisms for monocyte activation in co-culture with autologous tumor spheroids 2002 ·Cellular Immunology ·(unknown), John Helge Heimdal, Kenneth W. Kross, Jan Olofsson, Hans Jørgen Aarstad	9
20	Administration of human recombinant IL-7 to normal and irradiated mice increases the numbers of lymphocytes and some immature cells of the myeloid lineage 1992 ·The Journal of Immunology ·Connie R. Faltynek, (unknown), Diana Miller, Erik F. Young, Laura Tiberio, Kenneth W. Kross, Mark R. Kelley, (unknown)	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact